Thanks to the scholarship from the Norwegian Pharmaceutical Society, I had the opportunity to attend the 38th International Conference in PharmacoEpidemiology (ICPE2022) in Copenhagen together with many colleagues from Department of Pharmacy – UiO and Norwegian Institute of Public Health. We were excited to listen to cutting-edge research on “Advancing Pharmacoepidemiology and Real-World Evidence for the Global Community”. Among three oral presentations and twelve posters from PharmaSafe Group, I contributed one oral presentation and two posters as first author together with one oral presentation and two other posters as co-author as follows.
Nhung Trinh et al: Antidepressant Treatment in Pregnancy and Maternal Mental Health in the Postpartum Year: A Danish Registry Linkage Study in Pregnant Women with Obsessive‐compulsive Disorder – oral presentation
Nhung Trinh et al.: Association Between Antidepressant Use Patterns on The Long-Term Trajectories of Depressive and Anxiety Symptoms and Health-Related Quality of Life – Poster
Nhung Trinh et al.: Postpartum Episode of Eating, Mood, or Anxiety Disorder in Women with Eating Disorders Who Continue or Discontinue Antidepressant Treatment in Pregnancy – Poster
Angela Lupattelli et al: Association of Prenatal Antidepressant Exposure with Trajectories and Acceleration of Body Mass Index in Children from 6 Week to 8 Years of Age – oral presentation
Angela Lupattelli et al.: Antidepressant Continuation and Adherence in Pregnancy and Risk of Antenatal Hospital Admission for Depression and/or Anxiety – Poster
Angela Lupattelli et al.: Prenatal Exposure to Antidepressants and Risk of Overweight and Obesity in Offspring at Age 8 Years – Poster
It was also a nice opportunity to meet our international partners in person after two years working digitally. Notably, several colleagues and myself participated in the Special Interest Group Meeting on Medication in Pregnancy and Lactation and had a fruitful discussion about future collaborations and projects.